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ABSTRACT
Skin cancer is an important complication in renal trans-
plant recipients. Associations of transplant-related skin 
tumor with ultraviolet radiation, age at transplantation, 
type of immunosuppressant drug administered, and vi-
ral infection have been reported; however, the details re-
main unclear. We report a 61-year-old man who had un-
derwent renal transplantation at 38 years of age and de-
veloped multiple skin tumors or squamous cell carcino-
mas (SCCs). Polymerase chain reaction (PCR) analyses 
of the patient’s 12 tumors for viral DNAs of cutaneous 
or mucosal human papillomavirus (HPV) and 6 human 
polyomaviruses (MCPyV, trichodysplasia spinulosa-
associated, BK, JC, KI and WU polyomaviruses) only 
detected cutaneous HPV-DNA in only 5 of the tumors; 
no other viruses were detected. Real-time PCR showed 
high loads of cutaneous HPV in 3 SCCs and very low 
loads of MCPyV in 9. Immunohistochemistry revealed 
no tumor cell expression for MCPyV-large T-antigen or 
mucosal HPV. Our report not only reconfirmed the as-
sociation of cutaneous HPV5 with skin cancer in renal 
transplant recipients in previous studies but also showed 
no relevant association of 6 human polyomaviruses and 
mucosal HPV with skin tumors.
Key words    human papillomavirus; human polyoma-
virus; polymerase chain reaction renal transplantation; 
immunosuppression; skin cancer 
Skin cancer is an important complication in renal trans-
plant recipients. Associations with mainly ultraviolet ra-
diation, age at transplantation, type of immunosuppres-
sant drug administered, and viral infection have been 
reported,1, 2 although the details remain unclear. Numer-
ous studies have investigated the relationship between 
viral infection and skin cancer in renal transplant recipi-
ents.3, 4 however, these studies followed the same patient 
for several years and only few patients were examined 
for multiple viral infections.5, 6 We describe a renal 
transplant recipient who repeatedly presented with mul-
tiple skin cancers, in particular, squamous cell carcino-
ma (SCC). Twelve tumors were resected from the patient 
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in a span of 8 years (approximately 16–23 years after 
transplantation) and were examined for viral infection 
using PCR, real-time PCR and immunohistochemistry 
analyses. We examined the presence of viruses which 
have been reported in skin tumors including Merkel cell 
polyomavirus (MCPyV),5 cutaneous human papilloma-
virus (cutaneous HPV),6 mucosal human papillomavirus 
(mucosal HPV)7 and trichodysplasia spinulosa-associat-
ed polyomavirus (TSPyV).8 Furthermore, we also exam-
ined the presence of several polyomaviruses including 
BK polyomavirus (BKPyV),9 JC polyomavirus (JCPyV),9 
KI polyomavirus (KIPyV)10, 11 and WU polyomavirus 
(WUPyV).12, 13
 This report presents the patient and the results of ex-
amination for viruses previously described with a review 
of literature.
PATIENT REPORT 
This report was approved by the Institutional Review 
Board of Faculty of Medicine, Tottori University, 
Yonago 683-8503, Japan.
Patient report
A 61-year-old man who had undergone renal transplan-
tation because of chronic renal failure at 38 years of 
age who has since then under been immunosuppressant 
therapy with azathioprine and cyclosporine presented a 
red, dome-shaped, rapidly enlarging tumor on the back 
of his left hand of 25-mm diameter. The tumor was sur-
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gically resected, and was histopathologically diagnosed 
as keratoacanthoma (KA). The patient had no relevant 
family history (such as epidermodysplasia verruciformis 
Lewandowsky-Lutz14), smoking history or occupational 
exposure to carcinogens including pitch, tar, and arsenic. 
The first onset of skin lesions was 7 years after renal 
transplantation, involving multiple tumor formations on 
his trunk and limbs. Blood analyses showed no detect-
able abnormalities except for a slight elevation in lactic 
acid dehydrogenase levels (218 IU/L; standard value: 
106–211 IU/L). Since then, various skin lesions have oc-
curred, concentrating on the sun-exposed areas, includ-
ing the head and the forearms (Fig. 1). The lesions were 
treated with liquid nitrogen and lesions not effectively 
eliminated were surgically excised. Histopathologically, 
the lesions consisted of benign tumors such as KA, 
verruca vulgaris, Seborrheic keratosis, and malignant 
tumors such as SCC in situ, and SCC (Fig. 2). In this 
case, non-typical tumor formation is one of the charac-
teristics. The findings of tumors are not always exactly 
like the typically correct findings that are described in 
text books. Therefore, the pathological findings itself or 
descriptive term had to be adapted.
Samples and DNA extraction
Twelve skin tumors excised from the patient were ob-
tained from the archive of Yoka Hospital (Yabu, Japan). 
All cases were reviewed by pathologists, and the diag-
noses were confirmed (Table 1). Serial sections of all 
samples were used for hematoxylin and eosin staining 
Fig. 1. Locations of each tumor development. Tumors were 
focused on sun-exposed areas including the head and fore-
arm. Macroscopic and microscopic images of tumors are 
shown at Fig. 2.
Fig. 2. Macroscopic images (a–d) and microscopic 
images (e–h) are shown, respectively. a, e-1, e-2, e-3, 
tumor of No. 1 (KA); b, f, tumor of No. 12 (Seborrheic 
keratosis); c, g, tumor of No. 3 (SCC in situ); d, h, tumor 
of No. 4 (SCC) (haematoxylin and eosin stain). Bar of 
e-1, e-2, e-3, f, 2000 μm; g, h, 500 μm, respectively.
KA, keratoacanthoma; SCC, squamous cell carcinoma.
and DNA extraction. DNA was extracted from formalin-
fixed, paraffin-embedded (FFPE) samples of skin tu-
mors using QIAamp DNA FFPE Tissue Kit (Qiagen, 
Hilden, Germany), according to the manufacturer’s 
protocol. The concentrations of the extracted DNA were 
measured using NanoDrop 2000 spectrophotometer 
(Thermo Fisher Scientific, Waltham, MA).
 
Immunohistochemstry
To detect MVPyV large tumor antigen (LT) and muco-
sal HPV viral protein 1 (VP1) antigen, immunohisto-
chemistry was performed using mouse monoclonal anti-
body CM2B4 (diluted at 1:200; Santa Cruz Biotechnol-
ogy, Santa Cruz, CA) and mouse monoclonal antibody 
K1H8 (1:100; Dako, Glostrup, Denmark) as primary an-
tibody, respectively. Tissue sections were deparaffinized 
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and rehydrated. Endogenous peroxidase activity was 
blocked using 3% hydrogen peroxide for 5 min. Antigen 
retrieval was performed by incubating the sections in 
citrate buffer (pH 6.0) for 10 min at 95 °C. After apply-
ing the primary antibody, sections were incubated over-
night at 4 °C and then thoroughly washed in phosphate-
buffered saline. Peroxidase-conjugated goat anti-mouse 
IgG was applied as the secondary antibody. Sections 
were incubated for 60 min at room temperature and then 
washed in phosphate-buffered saline. Diaminobenzidine 
was used as the chromogen. But no immunoreactivity to 
MCPyV and mucosal HPV was detected in any of the 
tumor samples.
PCR
To detect viral DNA in each tumor sample, PCR was 
carried out using primers described elsewhere.8–13, 15–18 
The PCR products were approximately 100 base pairs 
in length (Table 2). To detect mucosal HPV, a mixture of 
short PCR fragment (SPF) 1A, 1B, 1C and 1D was used 
as forward primer and a mixture of SPF2B and 2D as 
reverse primer. PCR was performed using 0.25 U of Ta-
KaRa Ex Taq HS (Takara Bio, Ohtsu, Japan), 2.5 pmol 
of each deoxyribonucleoside triphosphate, 2.0 pmol 
Mg2+, 5 pmol of each primer pair and 10 ng of genomic 
DNA, generating a total volume of 10 pL per sample. 
Amplifications consisted of an initial denaturation for 4 
min at 95 °C and 40 cycles of denaturation for 30 s at 95 
°C, annealing for 30 s at 52 °C (for SPF primers) or at 59 
°C (for the other primers), an extension step for 1 min at 
72 °C and then, and a final extension for 4 min at 72 °C. 
Table 1. Tumors from the patient
No. Years after transplantation Location 
Size
(mm) Diagnosis 
1 16 Dorsal surface of right hand 28 KA
2 20 Forehead 10 SCC
3 20 Right forehead 12 SCC in situ
4 20 Left cheek 16 SCC
5 20 Dorsal surface of Left 1st digit 15 Verruca vulgaris
6 21 Left outer canthus 10 SCC
7 21 Right lower jaw 13 SCC
8 21 Right side of nose 5 Verruca vulgaris
9 23 Left ear pinna 12 SCC
10 23 Left cheek 9 SCC in situ
11 23 Dorsal surface of left hand 20 SCC
12 23 Front surface of right ear 9
Seborrheic kera-
tosis 
KA, keratoacanthoma; SCC, squamous cell carcinoma.
PCR products were electrophoresed, stained with ethid-
ium bromide, and visualized under UV light using UVP 
BioDoc-It System (UVP, Upland, CA).
Sequencing
To determine the sequence of the TaqMan probe used 
in quantitative PCR, sequencing was performed before 
quantitative PCR because the primers targeting the cu-
taneous and mucosal HPV were consensus primers for 
each type of HPV. The PCR products were purified be-
fore sequencing using NucleoSpin Gel and PCR Clean-
up (Takara Bio) according to the manufacturer’s proto-
col. Sequencing was performed using BigDye Termina-
tor v3.1 Cycle Sequencing (Thermo Fisher Scientific) 
on an Applied Biosystems 3130XL Genetic Analyzer 
(Thermo Fisher Scientific), and the resulting DNA se-
quences were compared against the reference sequences 
of GenBank (National Center for Biotechnology Infor-
mation, National Institute of Health, Bethesda, MD). 
The PCR results are shown in Table 3. Cutaneous HPV 
was detected in 5 of the 12 sample tumors. Sequence 
analysis identified cutaneous HPV as HPV5. MCPyV 
was detected in 9 of the 12 sample tumors. DNAs of 
mucosal HPV, BKPyV, JCPyV, TSPyV, KIPyV and 
WUPyV were not detected in any of the tumor samples.
Real-time PCR
To determine MCPyV and cutaneous HPV copy number 
in each of the samples examined as positive for these vi-
ruses at PCR, real-time PCR was performed using ABI 
PRISM 7900HT Sequence Detection System (Thermo 
Fisher Scientific). The PCR mixture to determine viral 
copy number contained 5.0 pL of THUNDERBIRD 
Probe qPCR Mix (Toyobo, Osaka, Japan), 3 pmol of the 
same primer pair as that of PCR, 2 pmol of fluorescein-
labeled TaqMan probe, 0.2 pL of 50× ROX reference dye 
(Toyobo) and 10 ng of genomic DNA, in total volume of 
10 pL per sample. The RNAse P gene was used as the 
internal control. The PCR mixture to determine RNAse 
P copy number contained 5.0 pL of THUNDERBIRD 
Probe qPCR Mix (Toyobo), 0.5 pL of 20× TaqMan copy 
number reference assay (Thermo Fisher Scientific), 0.2 
pL of 50 × ROX reference dye (Toyobo) and 10 ng of 
genomic DNA, in a total volume of 10 pL for each of the 
samples. Amplifications consisted of an initial denatur-
ation for 1 min at 95 °C and 45 cycles of denaturation for 
15 sec at 95 °C, annealing for 45 sec at 60 °C. Standard 
curves were drawn using positive controls of each of 
the viruses. The results of quantitative PCR analysis are 
shown in Table 4. TaqMan probes used in real-time PCR 
consisted of the universal probe library 22 (for MCPyV) 
and universal probe library 35 (for HPV 5), respectively. 
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Table 2. Primers for PCR
Virus Protein Product (bp) Sequence (5’–3’) 
MCPyV LT 76 F: AGGTTGACGAGGCCCCTAT
R: TTCCCGAAGCTGAATCCTC
Mucosal HPV VP1 66 SPF1A: GCICAGGGICACAATAATGG
SPF1B: GCICAGGGICATAACAATGG
SPF1C: GCICAGGGICATAATAATGG
SPF1D: GCICAAGGICATAATAATGG
SPF2B: GTIGTATCIACAACAGTAACAAA
SPF2D: GTIGTATCIACTACAGTAACAAA 
Cutaneous HPV E1 117 F: ACTGACCAAAGCTGGAAATC
R: TCTTGCAGAGCATTGAAACG 
BKPyV VP1 127 F: GCAGCTCCCAAAAAGCCAAA
R: CTGGGTTTAGGAAGCATTCTA 
JCPyV VP1 101 F: AGAAAAGGAGAAAGGAAGGACCC
R: TCTGTAATTGAGTCAACCCCAGTTT 
TSPyV NCCR 103 F: TCATACTGCCACAAACACAGGAAG
R: AGAACACAGAGCGGGAGGATG 
VP1 143 F: AGTCTAAGGACAACTATGGTTACAG
R: ATTACAGGTTAGGTCCTCATTCAAC 
LT 121 F: TGTGTTTGGAAACCAGAATCATTTG
R: TGCTACCTTGCTATTAAATGTGGAG 
KIPyV VP1 100 F: GGAAATACAGCTGCTCAGGAT
R: CTTTGATACTTGAACCGCTTTCCTT
WUPyV LT 77 F: TGTTGCATCCATTTGTTACATTCA
R: GAAAGAACTGTTAGACAAATATATAG 
E1, E1 protein; F, forward; HPV, human papillomavirus; JCPyV, JC polyomavirus; KIPyV, KI polyomavirus; LT, large tumor antigen; 
NCCR, non-coding control region; PCR, polymerase chain reaction; R, reverse; SPF, short PCR fragment; VP1, viral protein 1; WUPyV, 
WU polyomavirus.
Table 3. The results of PCR for viral DNAs
No. Diagnosis BKPyV JCPyV
TSPyV
KIPyV WUPyV MCPyV
Mucosal Cutaneous 
NCCR VP1 LT HPV HPV
1 KA – – – – – – – – – –
2 SCC – – – – – – – – – +
3 SCC in situ – – – – – – – + – +
4 SCC – – – – – – – + – +
5 Verruca vulgaris – – – – – – – + – –
6 SCC – – – – – – – + – –
7 SCC – – – – – – – + – –
8 Verruca vulgaris – – – – – – – + – –
9 SCC – – – – – – – – – –
10 SCC in situ – – – – – – – + – –
11 SCC – – – – – – – + – +
12 Seborrheic keratosis – – – – – – – + – +
BCPyV, BC polyomavirus; HPV, human papillomavirus; JCPyV JC polyomavirus; KA, keratoacanthoma; KIPyV, KI polyomavirus; LT, 
large tumor antigen; MCPyV, Merkel cell polyomavirus; NCCR, non-coding control region;  SCC, squamous cell carcinoma; TSPyV, 
trichodysplasia spinurosa-associated polyomavirus; VP1, viral protein 1; WUPyV, WU polyomavirus.
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Large copy numbers of HPV 5 were observed in 3 (No. 
3, 4 and 11) of the 12 tumor samples, and very low copy 
numbers of MCPyV were detected in 9 of 12 samples.
Table 4. The result of quantitative real-time PCR anal-
ysis
No. Diagnosis 
MCPyV
(copy/cell) 
Cutaneous HPV
(copy/cell) 
1 KA – –
2 SCC – ND
3 SCC in situ 0.000482  1.83
4 SCC 0.00340  146.0
5 Verruca vulgaris 0.0000531 –
6 SCC 0.00500 –
7 SCC 0.00103 –
8 Verruca vulgaris 0.000329 –
9 SCC – –
10 SCC in situ 0.00306 –
11 SCC 0.000286  1.69
12 Seborrheic keratosis 0.0466 ND
–, not tested because negative at PCR; HPV, human papillomavi-
rus; KA, keratoacanthoma; MCPyV, Merkel cell polyomavirus; 
ND, not detected; SCC, squamous cell carcinoma.
DISCUSSION
Skin cancer is an important complication in renal trans-
plant recipients. Incidence varies according to geograph-
ic latitudes; Naldi et al.19 reported that the incidence was 
approximately 5% after 5 years and 10% after 10 years 
in Italy. Bouwes et al.20 reported an incidence of 3% 
after 5 years and 16% after 11 years in Netherlands, and 
25% after 5 years and 45% after 11 years in Australia. 
These results suggest the association of ultraviolet radia-
tion with skin cancer in renal transplant recipients. In 
the population undergoing transplantation, the standard-
ized morbidity ratio compared with immunocompetent 
people is 60–250 times for SCC and 10–40 times for 
basal cell carcinoma (BCC).21 In addition, the SCC:BCC 
ratio is reversed compared with the ratio of 1:4 in the 
immunocompetent people.
 In Japan, the incidence of skin cancer is low. Arichi 
et al.22 examined 429 renal transplant recipients for 25 
years and reported 9 cases (2%) of skin cancers. On the 
other hand, Imao et al.23 (2007) reported the overall in-
cidence of malignancy in renal transplant recipients was 
6.8% (25/366 patients); however, no skin cancer cases 
have been documented in this population.
 In the present report, we examined 12 tumors from 
a 61-year-old man who previously underwent renal 
transplantation and presented with multiple skin can-
cers. In this case, non-typical tumor formation is one of 
the characteristic. The findings of tumors are not always 
correctly typical findings which are described in the 
text books. Therefore, the pathological findings itself 
or descriptive term had to be adapted (ex. SCC in situ). 
Neoplastic lesions developed on sun-exposed area. This 
suggests that the sun exposure is one of the important 
factor of tumor formation. In addition, we assumed that 
viral infection is another important factor coming from 
immunosuppression. Then we examined for viral effects 
using PCR assay and immunohistochemical assay. 
 At first, we tried immunohistochemical assay; 
however, since significant results were not obtained, we 
carried out PCR assay. The high viral load of cutaneous 
HPV (HPV5) was detected in 3 of the 12 tumors. HPV5 
has been often detected in skin cancer in renal transplant 
recipients; Barr et al.6 detected HPV5/8 in 15 (60%) of 
25 SCCs from 202 renal allograft recipients who had 
undergone kidney transplantations and were monitored 
over 3 years. In our case, although cutaneous HPV was 
not necessarily detected in all tumors, all 3 tumors from 
which cutaneous HPV was detected were SCCs, sug-
gesting that cutaneous HPV affects the development of 
skin cancer rather than the incidence.
 In terms of the association of MCPyV with skin 
cancer in renal transplant recipients, Mertz et al.6 ex-
amined 17 renal transplant recipients and 3 patients 
under long-term dialysis with skin tumors and detected 
MCPyV-DNA by PCR in 2 patients with Bowen’s dis-
ease. On the other hand as for MCPyV in nontumor tis-
sue, Matsushita et al. reported that MCPyV is prevalent 
in humans and was detected most frequently in the skin 
of 41 autopsy cases.24 We detected MCPyV-DNA in 
9 of 12 samples. But MCPyV is considered to have no 
relation to tumorigenesis in our patient, since their copy 
numbers were very low. 
 In terms of the relationship between the type of 
immunosuppressant and the incidence of skin cancer, 
previous studies have shown that patients immunosup-
pressed with azathioprine and cyclosporine showed 
higher rates of skin cancer than those on tacrolimus,20, 23 
although the finer details are currently under scrutiny.
 Our data suggests that there is a relationship be-
tween cutaneous HPV in skin cancer and renal trans-
plantation. Cutaneous HPV is influenced by other fac-
tors such as ultraviolet radiation, which increases the 
incidence and the development of skin cancer in renal 
transplant recipients. 
 Rogers et al.25 reported acquired epidermodysplasia 
verruciformis (epidermodysplasia verruciformis like 
syndrome). There is a common background such as im-
munodeficiency. However, in this case, tumors are not 
always flat warts (verruca plana), and few reports about 
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a very long follow up of many and multiple tumor for-
mation in the same patient after renal transplantation, 
as this case, is observed. Therefore, the relation of this 
case to acquired epidermodysplasia verruciformis is not 
always clear. Further studies are needed to better under-
stand the etiology of this malignancy.
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